Published in Front Microbiol on August 13, 2015
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
Anthrax. N Engl J Med (1999) 8.89
Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect Immun (1983) 5.69
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Anthrax vaccines: past, present and future. Vaccine (1991) 2.98
Selective killing of nonreplicating mycobacteria. Cell Host Microbe (2008) 2.39
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis (2004) 2.29
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10
An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med (2012) 2.10
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 2.03
Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity (2011) 1.95
Anthrax pathogenesis and host response. Curr Top Microbiol Immunol (1998) 1.83
Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe. Emerg Infect Dis (2012) 1.74
Molecular pathogenesis of Bacillus anthracis infection. Microbes Infect (1999) 1.68
Anthrax toxins: A paradigm of bacterial immune suppression. Trends Immunol (2006) 1.67
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis (2002) 1.51
Vaccines in a hurry. Vaccine (2009) 1.49
Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol (2002) 1.49
Public health in the time of bioterrorism. Emerg Infect Dis (2002) 1.46
The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc Natl Acad Sci U S A (2008) 1.44
gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med (1996) 1.35
Anthrax lethal and edema toxins in anthrax pathogenesis. Trends Microbiol (2014) 1.33
Molecular basis for improved anthrax vaccines. Adv Drug Deliv Rev (2005) 1.32
An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill (2010) 1.24
Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill (2012) 1.23
Bacillus anthracis, a bug with attitude! Curr Opin Microbiol (2001) 1.22
Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000. Euro Surveill (2013) 1.18
Current applications and future trends of molecular diagnostics in clinical bacteriology. Anal Bioanal Chem (2009) 1.17
Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008. Euro Surveill (2008) 1.16
Anthrax infection in drug users. Lancet (2010) 1.15
Detection technologies for Bacillus anthracis: prospects and challenges. J Microbiol Methods (2010) 1.14
Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009. MMWR Morb Mortal Wkly Rep (2010) 1.13
Advances in the development of next-generation anthrax vaccines. Vaccine (2009) 1.13
Injectional anthrax - new presentation of an old disease. Euro Surveill (2014) 1.12
Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. J Immunol (2006) 1.10
Bacillus cereus cellulitis from contaminated heroin. J Med Microbiol (2002) 1.02
Transcriptional profiling of Bacillus anthracis Sterne (34F2) during iron starvation. PLoS One (2009) 1.01
Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation. Infect Immun (2005) 0.97
The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax. FEMS Immunol Med Microbiol (2011) 0.97
Immunologic response of unvaccinated workers exposed to anthrax, Belgium. Emerg Infect Dis (2009) 0.94
Dendritic epidermal T cells regulate skin antimicrobial barrier function. J Clin Invest (2013) 0.94
Anthrax infection among heroin users in Scotland during 2009-2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis (2012) 0.93
Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein. PLoS One (2009) 0.93
Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice. Infect Immun (2010) 0.90
Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro. J Immunol (2013) 0.89
Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users. BMC Infect Dis (2013) 0.88
Bacterial population genomics and infectious disease diagnostics. Trends Biotechnol (2010) 0.87
Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010. Emerg Infect Dis (2014) 0.87
Anthrax in injecting drug users: the need for increased vigilance in the clinic. Expert Rev Anti Infect Ther (2015) 0.86
Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease. J Bacteriol (2013) 0.85
Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R. PLoS One (2013) 0.84
Colonic immune suppression, barrier dysfunction, and dysbiosis by gastrointestinal bacillus anthracis Infection. PLoS One (2014) 0.84
Immune response biomarker profiling application on ProtoArray protein microarrays. Methods Mol Biol (2010) 0.83
Diagnosing emerging and reemerging infectious diseases: the pivotal role of the pathologist. Arch Pathol Lab Med (2011) 0.82
Epidemiological findings and medical, legal, and public health challenges of an investigation of severe soft tissue infections and deaths among injecting drug users -- Ireland, 2000. Epidemiol Infect (2005) 0.81
Injectional anthrax infection due to heroin use induces strong immunological memory. J Infect (2014) 0.81
Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design. Expert Rev Vaccines (2014) 0.79
Recognition and treatment of anthrax. JAMA (1999) 0.79
Anthrax vaccines. Ann Saudi Med (2005) 0.79
Acute infections in intravenous drug users. Clin Med (2013) 0.79
Learning from the 2001 anthrax attacks: immunological characteristics. J Infect Dis (2006) 0.78
Impaired colonic B-cell responses by gastrointestinal Bacillus anthracis infection. J Infect Dis (2014) 0.78
Lung B cells promote early pathogen dissemination and hasten death from inhalation anthrax. Mucosal Immunol (2012) 0.77
Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells. Infect Immun (2014) 0.77
Peptide microarrays on coated silicon slides for highly sensitive antibody detection. Methods Mol Biol (2010) 0.77
Severe systemic Bacillus anthracis infection in an intravenous drug user. BMJ Case Rep (2014) 0.76
Fatal cutaneous anthrax in a heroin user. J Laryngol Otol (2013) 0.75